Literature DB >> 12548612

Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge.

Daigo Yamamoto1, Hideto Senzaki, Hiroyuki Nakagawa, Homa Okugawa, Hideki Gondo, Kanji Tanaka.   

Abstract

BACKGROUND: Breast carcinoma and precancer are believed to start in the lining of the milk duct or lobule. Ductography and fiberoptic ductoscopy (FDS) are used to identify abnormal intraductal lesions, although it is difficult to distinguish malignant from benign cases. Therefore, we studied the clinical usefulness of fluorescence in situ hybridization (FISH) analysis of a numerical aberration of chromosomes (aneusomy) using ductal lavage from patients with nipple discharge.
METHODS: We applied ductography and FDS to 90 women who had nipple discharge. Ductal lavages obtained from patients with positive ductography and/or FDS findings were subjected to cytology and FISH analysis using centromere probes for chromosomes 1, 11, and 17. Patients with samples that showed aneusomy in at least one of the three chromosomes were diagnosed as positive.
RESULTS: Histologic evaluation revealed 54 benign lesions and six malignancies. The sensitivity, specificity, and diagnostic accuracy were 33.3%, 88.9%, and 83.3%, respectively, for cytology and 100%, 100%, and 100%, respectively, for FISH.
CONCLUSION: The results demonstrated that FISH has a diagnostic accuracy comparable to cytology. This technique has 100% specificity is making a definitive diagnosis of malignancy in patients with indeterminate cytologic results, suggesting that FISH diagnosis can be a good adjunct to cytology. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11091

Entities:  

Mesh:

Year:  2003        PMID: 12548612     DOI: 10.1002/cncr.11091

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer.

Authors:  V Dutta; G S Chopra; K Sahai; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

3.  Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis.

Authors:  Farkhondeh Behjati; Morteza Atri; Hossein Najmabadi; Keramat Nouri; Mahdi Zamani; Parvin Mehdipour
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

4.  Duct Excision is Still Necessary to Rule out Breast Cancer in Patients Presenting with Spontaneous Bloodstained Nipple Discharge.

Authors:  R E Foulkes; G Heard; T Boyce; R Skyrme; P A Holland; C A Gateley
Journal:  Int J Breast Cancer       Date:  2011-09-06

5.  The Fourth International Symposium on the Intraductal Approach to Breast Cancer, Santa Barbara, California, 10-13 March 2005.

Authors:  Bonnie L King; Susan M Love; Susan Rochman; Julian A Kim
Journal:  Breast Cancer Res       Date:  2005-07-20       Impact factor: 6.466

Review 6.  The intraductal approach to the breast: raison d'être.

Authors:  Bonnie L King; Susan M Love
Journal:  Breast Cancer Res       Date:  2006-04-21       Impact factor: 6.466

Review 7.  Ductal approaches to assessment and management of women at high risk for developing breast cancer.

Authors:  Imogen Locke; Gillian Mitchell; Rosalind Eeles
Journal:  Breast Cancer Res       Date:  2004-01-26       Impact factor: 6.466

8.  Accuracy for cytological evaluation in the detection of breast cancer among patients with pathologic nipple discharge: a PRISMA-compliant meta-analysis.

Authors:  Xiao-Qian Li; Feng Xu; Chu-Qi Lei; Jie Li; Hong-Chuan Jiang
Journal:  Chin Med J (Engl)       Date:  2020-02-20       Impact factor: 2.628

9.  Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.

Authors:  Manal F Ismail; Magdy Sayed Aly; Hussein M Khaled; Hanaa M Mohamed
Journal:  Ger Med Sci       Date:  2009-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.